SCHEMBL13639844

SCHEMBL13639844

C=C/C=C(\C=C/C)C(=O)/C=C/c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.47
GLA P06280 1/20 0.47
MAPT P10636 4/20 0.46
LMNA P02545 3/20 0.46
ALDH1A1 P00352 3/20 0.46
HDAC3 O15379 2/20 0.46
HDAC4 P56524 2/20 0.46
HDAC1 Q13547 2/20 0.46
HDAC2 Q92769 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
PLIN1 O60240 2/20 0.46
RECQL P46063 2/20 0.46
PLIN5 Q00G26 2/20 0.46
ABHD5 Q8WTS1 2/20 0.46
F3 P13726 2/20 0.46
TNKS O95271 1/20 0.46
HCAR2 Q8TDS4 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC10 Q969S8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20828502 0.85 TDP1 (0.55) TDP1GLAMAPTLMNAALDH1A1
SCHEMBL24603 0.82 MAPT (0.50) TDP1GLAMAPTLMNAALDH1A1
SCHEMBL21158994 0.79 GLA (0.49) TDP1GLAMAPTLMNAALDH1A1
SCHEMBL1336837 0.79 GLA (0.56) TDP1GLAMAPTLMNAALDH1A1
SCHEMBL3803608 0.78 MAPT (0.53) TDP1GLAMAPTLMNAALDH1A1
SCHEMBL24435651 0.76 F3 (0.56) TDP1GLAMAPTLMNAALDH1A1
SCHEMBL13621556 0.76 CES2 (0.43) MAPTLMNAALDH1A1RECQLCYP1A2
SCHEMBL4173173 0.75 GLA (0.51) TDP1GLAMAPTLMNAALDH1A1
SCHEMBL26636136 0.75 HTT (0.54) TDP1GLAMAPTALDH1A1HDAC3
SCHEMBL19872825 0.74 GLA (0.42) TDP1GLAMAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12016312-B2 Animal models, screening methods, and treatment methods for intraocular diseases or disorders Smilebiotek Zhuhai Limited (CN) 2024-06-25 US disclosed
US-20220015338-A1 ANIMAL MODELS, SCREENING METHODS, AND TREATMENT METHODS FOR INTRAOCULAR DISEASES OR DISORDERS Smilebiotek Zhuhai Limited (CN) 2022-01-20 US disclosed
EP-2520632-A2 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE COMPOUND Cheil Industries Inc. (KR) 2012-11-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12016312-B2 Animal models, screening methods, and treatment methods for intraocular diseases or disorders MB, MYOC, PDE6A TDP1 1381/4885GLA 31/4885MAPT 2250/4885
US-20220015338-A1 ANIMAL MODELS, SCREENING METHODS, AND TREATMENT METHODS FOR INTRAOCULAR DISEASES OR DISORDERS MB, MYOC, PDE6A TDP1 1381/4885GLA 31/4885MAPT 2250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.